Veracyte, Inc.VCYT

Healthcare
Bullish

ASignal's systematic analysis rates VCYT as Bullish. Veracyte, Inc. has a market cap of $3.89B, a P/E of 45.12, a 16.3% net margin, and 21.5% year-over-year revenue growth.

Reflects the latest available analysis · analyzed Jun 7, 2026

The case on VCYT

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong revenue growth (21.5% YoY)
  • Exceptional earnings growth (288.9% YoY)
  • High gross margin (72.91%) indicating pricing power
  • Strong free cash flow ($104.51M)
  • Low debt-to-equity ratio (0.03x)
  • High cash position ($439.06M) relative to debt
VS
Bear case
  • RSI at 77.42, indicating overbought conditions
  • High P/E ratio (45.12x) relative to market
  • Forward P/E still elevated at 25.63x
  • Low ROE (6.93%) despite strong growth
  • PEG ratio not available, suggesting growth may not be fully supported by fundamentals
  • No Reddit mentions, indicating lack of retail investor interest

Key facts

Sector
Healthcare
Market cap
$3.89B
P/E ratio
45.12
Gross margin
72.9%
Net margin
16.3%
Rev growth YoY
21.5%
Price (Jun 7, 2026)
$48.73
Subscriber-only

See the full verdict on VCYT

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes VCYT

Most investors never get a second opinion, let alone several. ASignal runs VCYT past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

Veracyte, Inc. (VCYT) Stock Analysis - ASignal rates it Bullish